4Filing Date: Sep 10, 2026

Metlife

Statement of Changes in Beneficial Ownership

View SEC Filing
ACC: 0001714199-26-000011
Total Value$11.0K
Trades1
Insiders1

Transaction Details

TADROS RAMY
President, U.S. Business·Direct
Grant · Acquire
Common Stock
Shares+115
Price$95.50
Total Value$11.0K
Shares Owned After212.69K
Transaction DateSep 8, 2026
Footnotes ▸

Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Leadership Deferred Compensation Plan. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the reporting person has deferred.

Post-Transaction Holdings

TADROS RAMY · President, U.S. Business
SecuritySharesChange
Common Stock212.69K+115 (0.05%)
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-09-08 10b5-1 Pre-arranged Plan: No --- Issuer --- Name: METLIFE INC (MET) CIK: 0001099219 --- Reporting Owner --- Name: TADROS RAMY CIK: 0001714199 Role: Officer (President, U.S. Business) --- Non-Derivative Transactions --- [Transaction #1] Security: Common Stock Date: 2026-09-08 | Code: A (Grant or award) Shares: +115 | Price: $95.50 Total Value: $10,982.50 Shares Owned After: 212,695 | Ownership: D (Direct) Footnotes: [F1] Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Leadership Deferred Compensation Plan. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the reporting person has deferred. --- Footnotes (Complete Index) --- F1: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Leadership Deferred Compensation Plan. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the reporting person has deferred. --- Signature --- /s/ /s/ Morgan Keehner-Jones Mayes, Attorney-in-fact (2026-09-10)

keid analysis is for reference only and does not constitute investment advice.